The Biotech Frontier: A Beginner’s Hub

If you’ve been following AI, you already know roughly half the story of what’s happening in technology right now. The other half is biology. The companies running fast on AI are also running fast on protein design, gene therapy, synthetic embryos, brain-computer interfaces, and bringing back species that have been extinct for hundreds of years. The two fields feed each other. AlphaFold solved protein structure prediction in 2020 and unlocked drug discovery. AI is now doing the heavy lifting in genome design, lab automation, and drug screening. Biology is now where AI’s deepest near-term consequences land.

This hub is the Beginners in AI guide to the biotech frontier. Plain English. No assumed background. When we have to use a technical term, we link to the AI Glossary. Same promise as the rest of the site: we explain the technology so you can have a better life, and we put the human first.

What is biotech, really?

Biotech is short for biotechnology. It’s any use of living systems (cells, DNA, proteins, microbes, organs) to make something useful. The bread you ate today is biotech (yeast is doing the work). So is the insulin a diabetic friend uses (made by genetically engineered bacteria). So is the COVID-19 vaccine that protected your family in 2021. The word covers a wide range, from things humans have done for thousands of years to things we figured out last month.

What’s new in the 2020s is the speed. CRISPR (a way to edit DNA precisely) was invented in 2012 and won the Nobel Prize in 2020. AlphaFold (an AI that predicts protein structure) released its first model in 2018 and the proteome (the full set of human proteins) was solved by 2022. Lab automation now lets a small team run thousands of experiments in a week that would have taken a year a decade ago. The cost of sequencing a human genome dropped from $100 million in 2001 to around $200 today.

Why should a non-scientist care?

Three reasons:

• It’s coming to your life faster than AI did. Gene-edited therapies for sickle-cell disease (Casgevy) and a handful of cancers are FDA-approved now. Lab-grown meat is in restaurants in Singapore and the US. Personalized cancer vaccines (mRNA-based, individually designed using AI) are in late-stage trials. You will encounter biotech in the doctor’s office, the grocery store, and the news within five years.
• The arguments matter. Should we bring back the woolly mammoth? Edit embryos to prevent disease? Grow meat without animals? Resurrect the dodo? These choices are being made now. A person with the basic vocabulary can participate in the conversation. A person without it gets steamrolled.
• The technology is genuinely beautiful. Watching a scientist crack open an egg, pour its contents into a 3D-printed lattice, and have a healthy chick hatch out the other side is the kind of moment that pulls people back into being curious about the world. We will write about a lot of those moments.

What does Beginners in AI cover in biotech?

The plan is to cover the same territory we cover in AI, but for biology and adjacent sciences. Specific topics on the docket:

• De-extinction and synthetic embryos. Bringing back the mammoth, the dodo, the thylacine. The new artificial eggshell that just hatched 26 chicks. The mouse embryos grown from stem cells without sperm or egg.
• CRISPR and gene editing. What it actually is. The Casgevy sickle-cell cure. CRISPR babies (and why the scientist who made them is in prison). Whether you should edit out a disease before birth.
• Protein design. AlphaFold and what it changed. AI-designed antibodies. The way new drugs will be made starting in the 2030s.
• Brain-machine interfaces. Neuralink’s first patient. Synchron’s stentrode. EEG advances. The handwriting-versus-typing brain research from Norway (see our deep dive: Why writing by hand activates more of your brain than typing).
• Lab-grown meat and synthetic biology. Cultured chicken and beef. Engineered microbes that produce vanilla, leather, even spider silk.
• Personalized medicine. mRNA cancer vaccines. Genome-based dosing. The 23andMe-era of consumer genomics, what it tells you, and what it doesn’t.
• Biosecurity. The harder question: what happens when these tools are cheap enough to misuse?

Start here: the artificial eggshell story

The cleanest starting point is the story breaking the day we launched this hub. On May 19, 2026, the de-extinction company Colossal Biosciences announced that it had hatched 26 healthy chickens from a fully artificial eggshell, a 3D-printed lattice with an engineered membrane and a clear window for scientists to watch the embryo develop in real time. The technique is a step toward growing extinct-species embryos that no living bird could lay.

Our explainer covers what they actually built, how it works, why it’s needed for de-extinction, and the bigger questions about ecology, ethics, and what it means to bring a species back at all.

The Beginners in AI position on biotech

We are pro-technology. Biotech is one of the most consequential fields of the century. Used well, it ends diseases that have killed billions, restores ecosystems we broke, and produces food without the cost of factory farming.

We are also pro-human first. The technology is at its best when it enhances life, not when it overrides our judgment about what we want life to look like. Gene editing for sickle-cell disease is a clear win. Editing embryos to make children taller is a different kind of question, and the human answer matters more than the technical one. A 2024 Norwegian EEG study showed that writing by hand builds neural connections typing skips, a small reminder that even when the technology exists to skip a step, the human still benefits from doing it. The same principle applies across biotech.

We will write about each new breakthrough with the same lens: what it is, how it works, who benefits, what could go wrong, and what choices the public actually has.

How does this connect to AI?

Closer than most readers realize. A short list:

• AlphaFold is an AI model that predicts the 3D structure of any protein from its amino-acid sequence. It made decades of protein chemistry irrelevant. Every drug company now uses it.
• RFdiffusion (David Baker’s lab, University of Washington) is an AI that designs new proteins that have never existed. New antibodies, new enzymes, new vaccines.
• CRISPR guide design uses machine learning to predict which guide RNAs will edit DNA accurately and avoid off-target effects.
• Drug-screening pipelines are now run by AI agents that test thousands of molecules a week and prioritize the candidates worth bench testing.
• Synthetic-embryo development models (the mouse embryo grown from stem cells) use AI for image analysis of cell behavior.

AI is the lab assistant that biology has been waiting for. Biology, in turn, is one of the biggest application surfaces for AI. The story we will tell across this hub treats the two as one frontier.

Frequently asked questions

Why is a site called Beginners in AI covering biotech?

Because AI doesn’t exist in a vacuum. The companies building AI are also building biology. The breakthroughs in protein design, drug discovery, and synthetic embryos all run on AI underneath. Understanding how technology works helps people have better lives, which is our mission. We just expanded the boundary of “technology” past what most beginner sites do.

How is the hub going to be organized?

The same way our AI hubs work. A topic hub at the top, plain-English explainers for each subtopic, and direct links to primary sources (Nature, Science, company announcements, university press releases). When a term is technical and we have to use it, we link to the AI Glossary. If the term is biology-specific and not in the glossary yet, we add an entry.

How often will you publish biotech posts?

As often as a story justifies it. We won’t run a daily biotech newsletter and we won’t try to keep up with every paper. We’ll cover the stories that matter to a non-scientist’s life and the bigger debates that affect policy and ethics.

What about other technology hubs?

Biotech is the first. Robotics is already in flight (we have a cluster on humanoids and drones). Energy, quantum, and space are next. Same approach for all of them: beginner-readable, primary sources, pro-human first.

Sources and further reading

• Colossal Biosciences, de-extinction company building the mammoth, dodo, thylacine, and now the artificial eggshell
• AlphaFold, Google DeepMind’s protein-structure prediction model
• Baker Lab at University of Washington, leaders in AI protein design (RFdiffusion)
• Nature: Biotechnology, the field’s main journal
• Science Magazine, primary source for major papers
• STAT News, best daily journalism on biomedicine

You might also like

• 26 Healthy Chicks Just Hatched From a 3D-Printed Artificial Egg
• AlphaFold Explained: How AI Solved Protein Folding
• How AI Is Changing Drug Discovery
• AI Brain Reading at 74% Accuracy: What It Means
• Why Writing By Hand Activates More of Your Brain Than Typing
• AI in Healthcare: A Beginner’s Guide
• Beginners in AI Special Reports
• AI Glossary